Pacira BioSciences (PCRX) Amortization - Intangibles (2019 - 2026)

Pacira BioSciences' Amortization - Intangibles history runs 8 years deep, the most recent figure standing at $14.3 million for Q1 2026.

• On a quarterly basis, Amortization - Intangibles changed 0.15% year-over-year to $14.3 million in Q1 2026; TTM through Mar 2026 was $57.2 million, a 0.04% change from a year earlier, with the FY2025 full-year figure at $57.3 million, changed 0.0% from the prior year.
• Amortization - Intangibles steadied at $14.3 million in Q1 2026 per PCRX's latest filing, from $14.3 million in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $14.3 million in Q3 2022 and bottomed at $14.3 million in Q4 2024.
• The 5-year median for Amortization - Intangibles is $14.3 million (2022), against an average of $14.3 million.
• Across the five-year window, Amortization - Intangibles surged 628.11% in 2022 and declined 0.24% in 2024, its largest moves.
• Year by year, Amortization - Intangibles stood at $14.3 million in 2022, then changed by 0.0% to $14.3 million in 2023, then retreated by 0.24% to $14.3 million in 2024, then changed by 0.0% to $14.3 million in 2025, then gained by 0.24% to $14.3 million in 2026.
• Per Business Quant, the three latest PCRX Amortization - Intangibles figures stand at $14.3 million (Q1 2026), $14.3 million (Q4 2025), and $14.3 million (Q3 2025).